2024-10-05 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**Company Overview:** Intuitive Surgical Inc. is a leading provider of robotic-assisted surgical systems and related instruments and accessories.

**1. Performance vs. S&P 500:**

* **Cumulative Return (ISRG):** 350.36%
* **Cumulative Return (VOO):** 131.45%
* **Difference:** 218.91%
* **Relative Divergence:** 75.7%

ISRG has outperformed the S&P 500 significantly, with its cumulative return more than double that of VOO. This outperformance is reflected in the high relative divergence, indicating ISRG's performance is currently in the 75.7th percentile of its historical range compared to VOO.

**2. Recent Price Movement:**

* **Closing Price:** 486.62
* **5-Day Moving Average:** 486.22
* **20-Day Moving Average:** 485.39
* **60-Day Moving Average:** 468.80

The stock is currently trading slightly above its 5-day and 20-day moving averages, suggesting a potential short-term upward trend. However, the 60-day moving average is lower, indicating some potential for a pullback.

**3. Technical Indicators:**

* **RSI:** 43.03
* **PPO:** -0.22
* **Delta_Previous_Relative_Divergence:** -1.48 (Short-term downward trend)
* **Expected Return:** 8.4% (Over 5 years, relative to VOO)

The RSI suggests the stock is currently in a neutral range, neither overbought nor oversold. The PPO indicates a slight downtrend. The negative Delta_Previous_Relative_Divergence suggests a potential short-term downward trend. The Expected Return of 8.4% is positive, indicating a potential for further growth over the next 5 years, but it should be considered within the context of the overall market performance.

**4. Recent Earnings and Outlook:**

| Date       | EPS   | Revenue        |
|------------|-------|-----------------|
| 2024-07-19 | 1.48  | $2.01 Billion   |
| 2024-04-19 | 1.54  | $1.89 Billion   |
| 2023-10-20 | 1.18  | $1.74 Billion   |
| 2023-07-24 | 1.20  | $1.76 Billion   |
| 2024-07-19 | 1.20  | $1.76 Billion   |

The recent earnings show consistent growth in both EPS and revenue. While the latest earnings report for 2024-07-19 is not yet available, analysts expect earnings per share to be in the range of $1.20 to $1.30. The continued growth in earnings and revenue suggests a positive outlook for the company. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** The stock is currently trading at a higher price-to-earnings ratio (P/E) compared to the broader market, but investors continue to see value in its dominant position in the robotic surgery market. 
* **Analyst Opinions:** Many analysts are optimistic about Intuitive Surgical's long-term prospects, driven by growing demand for minimally invasive surgical procedures and the company's continuous innovation. The company's strong market share and its focus on developing new technologies and expanding its product portfolio are key drivers for this optimism. 
* **Performance Highlights:** The company recently announced strong second-quarter results, beating analysts' expectations on both earnings and revenue. The growth was driven by strong demand for its flagship da Vinci surgical system.

**6. Overall Analysis:**

Intuitive Surgical Inc. continues to be a strong performer, with a significant track record of outperforming the S&P 500. Recent earnings suggest a positive outlook for the company, but the stock is currently trading at a higher P/E ratio, which could be a factor to consider for potential investors. Despite the slight downtrend in some technical indicators, the overall positive outlook for the robotic surgery market and Intuitive Surgical's position within it makes the company a promising investment option. However, further analysis of the market and company specific risks should be considered before making any investment decisions. 

**7. Disclaimer:** This analysis is for informational purposes only and should not be considered as financial advice. Please consult with a qualified financial advisor before making any investment decisions.